The global Dialyzer market value in 2023 was USD 6.50 billion driven by the growing demand for home-based dialysis treatment across the globe. The market size is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032 to achieve a value of USD 11.97 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to dominate the dialyzer market in the forecast period of 2024-2032. The increasing prevalence of diseases, such as hypertension, end-stage renal disease (ESRD), diabetes, and other chronic diseases in the region are expected to drive the growth of the dialyzer market. The rise in the number of patients suffering from end-stage renal disease (ESRD) increases the need for haemodialysis, propelling the market's growth. The improved diagnosis, growing per capita health care spending, and high disposable income of the population further expected to further propel the market growth of dialyzers in North America.
Asia Pacific is expected to grow at the fastest CAGR during the forecast period owing to the higher adoption of haemodialysis to treat kidney-related diseases in the geriatric population. Along with this, the infrastructure development in the healthcare sector is serving a favourable environment for the installation of dialyzers and has ample space for performing the procedure. This is anticipated to propel the market growth of dialyzer in the Asia Pacific region during the forecast period. The increasing health care expenditure, presence of developing economies, and constantly growing population further adds to the region's market growth.
A dialyzer, also known as an artificial kidney, is an instrument that utilises a thin and fibrous membrane to create a semipermeable membrane which allows tiny particles and liquids to flow through. When the kidneys are unable to work effectively, it is a cost-effective therapy that eliminates excess fluids and wastes from the blood, preventing salt accumulation and poisoning.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on flux type, the market is segmented into:
On the basis of usage, the market is divided into:
The end-uses of the market are:
The regional markets for the dialyzers market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
There has been a significant rise in population suffering from diabetes, hypertension, heart disease, and end-stage renal disease (ESRD). This, combined with the world's growing geriatric population, is one of the primary drivers driving the global market growth. The growing funding for improving dialysis products and services by governments of several countries is propelling the market's growth. Also, the higher efficiency of high-flux dialysers to remove large size toxin molecules during the haemodialysis has been bolstering the growth of the market. Further, the shortage of kidneys for transplantation across the globe is offering lucrative growth opportunities to key market players. The rising utilisation of novel products to treat chronic kidney conditions is catalysing the demand for dialyzers worldwide. The industry is also influenced positively by the availability of qualified medical staff in dialysis centres who provide better services to patients. Additionally, the expanding healthcare industry, rising medical tourism, improving reimbursement regulations, and technological advancements in product manufacture are some of the other growth-inducing factors. The global dialyzer industry is likely to benefit from technology improvements that lead to increased usage and demand in developing countries.
The report gives a detailed analysis of the following key players in the global dialyzers industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Flux type||
|Breakup by Usage||
|Breakup by End User||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Dialyzer Market Overview
3.1 Global Dialyzer Market Historical Value (2017-2023)
3.2 Global Dialyzer Market Forecast Value (2024-2032)
4 Global Dialyzer Market Landscape
4.1 Global Dialyzer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Dialyzer Product Landscape
4.2.1 Analysis by Flux Type
4.2.2 Analysis by Uses
4.2.3 Analysis by End User
5 Global Dialyzer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Dialyzer Market Segmentation
6.1 Global Dialyzer Market by Flux Type
6.1.1 Market Overview
6.1.2 High Flux
6.1.3 Low Flux
6.2 Global Dialyzer Market by Usage
6.2.1 Market Overview
6.3 Global Dialyzer Market by End User
6.3.1 Market Overview
6.3.2 In Centre Dialysis
6.3.3 Hospital Dialysis
6.3.4 Home Dialysis
6.3.5 Independent Dialysis
6.3.6 Peritoneal Dialysis
6.3.7 Home Haemodialysis
6.4 Global Dialyzer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Dialyzer Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Dialyzer Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Dialyzer Market
9.1 Market Share by Country
10 Latin America Dialyzer Market
10.1 Market Share by Country
11 Middle East and Africa Dialyzer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Baxter International, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Nipro Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Nikkiso Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Asahi Kasei Medical Co., Ltd.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 JMS Co., Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 B. BRAUN MELSUNGEN AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 BROWNDOVE HEALTHCARE (P) LTD.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 BAIN MEDICAL EQUIPMENT
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 FRESENIUS MEDICAL CARE AG & CO. KGAA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 KAWASUMI LABORATORIES INC.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 MEDTRONIC PLC. (BELCO)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 ALLMED MEDICAL CARE HOLDINGS LIMITED
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 WEIGAO GROUP
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15 CHINA CHENGDU WESLEY BIOTECH CO., LTD
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.16 MEDICA GROUP
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.17 TORAY INDUSTRIES, INC.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.18 MEDIVATORS, INC.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
18 Global Dialyzer Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
Globally, dialyzer market reached a value of USD 6.50 billion in 2023.
The market is projected to expand at a CAGR of 7.2% from 2024 to 2032, growing to USD 11.97 billion by 2032.
The major drivers of the market include the shortage of kidneys for transplantation, rising utilisation of novel products to treat chronic kidney conditions, availability of qualified medical staff in dialysis centres, expanding healthcare industry, rising medical tourism, improving reimbursement regulations, growing geriatric population and technological advancements.
Rise in the prevalence of diabetes, hypertension, and end-stage renal diseases (ESRD) and higher adoption of haemodialysis to treat kidney-related diseases are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on flux type, the market is segmented into high flux and low flux, among others.
On the basis of usage, the market is divided into disposable and reusable.
The product finds end-uses in centre dialysis, home dialysis, hospital dialysis, independent dialysis, peritoneal dialysis, and home hemodialysis.
The major players in the industry are Baxter International, Inc., Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., and JMS Co., Ltd., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.